A clinician by training, Charlie is co-founder and Chief Partnership Officer at Freenome, focusing on mid- and longer-term relationships that will help define the company’s future directions and revenues. He works closely with the business development team in managing corporate client accounts and institutional collaborations.
Prior to co-founding Freenome, Charlie co-founded a company that uses circulating cell-free (cf)DNA from maternal blood samples to diagnose chromosomal abnormalities during pregnancy. The resulting in-vitro diagnostic, IONA, has been marketed successfully across Europe and the Middle East.
Charles studied medicine and neuropsychology in the U.K., earning a Masters degree from the University of Oxford with a focus on immunotherapy. He has worked in some of the UK’s leading oncology centers, including the Royal Marsden.